Park Medi World Limited IPO
Park Medi World Limited is the second largest private hospital chain in North India with 3,000 beds, operating 14 NABH-accredited multi-super specialty hospitals across four states, supported by 1,014 doctors and 2,142 nurses. Established from its first hospital in 2005, the Company has rapidly expanded through strategic greenfield projects and eight successful acquisitions—now contributing over 55% of its revenue and profitability—demonstrating strong execution and integration capabilities.
Extensive Hospital Network and Bed Capacity
The Company has expanded its bed capacity from 2,550 in FY23 to 3,250 as of September 30, 2025, and is undertaking major growth projects across Ambala, Panchkula, Rohtak, Gorakhpur, Kanpur, and Narela. These include new hospitals, capacity upgrades, and strategic acquisitions, which are expected to increase total bed capacity to 4,900 by March 31, 2028.
Strategic Approach and Operating Model
The Company adopts a cluster-based expansion strategy, allowing hospitals in nearby locations to share resources, improve efficiency, and benefit from economies of scale. This model enhances cost management and margins, while a diversified payor mix across cash, corporate, government, and insurance segments ensures stable and balanced revenues.
Clinical Infrastructure and Specialty Services
Park Medi World operates advanced clinical infrastructure comprising:
– 870 ICU beds
– 67 operating theatres
– Two comprehensive cancer units equipped with linear accelerators
– Oxygen generation plant at each hospital
– 24×7 trauma and emergency care with specialist coverage
The Company has also established Institutes of Minimal Access, Advanced Surgical Sciences and Robot-Assisted Surgery (iMARS) at Gurugram (Sector 47), Palam Vihar, and Mohali, offering robotic and minimally invasive surgeries for improved patient outcomes.
Objects of the Park Medi World Limited IPO:
Park Medi World Limited IPO Details:
| Open Date: | Dec 10 2025 |
| Close Date: | Dec 12 2025 |
| Total Shares: | 5,67,90,123 |
| Face Value: | ₹ 2 Per Equity Share |
| Issue Type: | Book Building |
| Issue Size: | 920 Cr. |
| Lot Size: | 92 Shares |
| Issue Price: | ₹ 154 - 162 Per Equity Share |
| Listing At: | NSE,BSE |
| Listing Date: | Dec 17 2025 |
Promoters And Management:
Financials of Park Medi World Limited IPO:
| Particulars | 6M FY2025-26 | 6M FY2024-25 | FY 2024-25 | FY 2023-2024 | FY 2022-2023 |
| Revenue from Operations (Cr) | 808.60 | 691.50 | 1393.50 | 1231.00 | 1244.50 |
| EBITDA (Cr) | 217.10 | 189.50 | 372.10 | 310.30 | 390.30 |
| EBITDA Margins | 26.85% | 27.42% | 26.71% | 25.21% | 3.11% |
| PAT (Cr) | 139.1 | 112.8 | 213.2 | 152 | 228.1 |
| PAT Margins | 17.21% | 16.33% | 15.30% | 12.35% | 18.19% |
| ROCE | 9.55% | 9.63% | 17.47% | 16.07% | 26.78% |
| D/E Ratio | 0.58 | 0.62 | 0.61 | 0.73 | 0.79 |
| OPerating Cash Flow | 45.4 | 118.9 | 191.5 | 361.45 | 195 |
Comparison With Peers:
| Companies | Revenue (in cr) | EBITDA Margins | PAT Margins | ROCE | D/E Ratio | MCap (in cr) | P/E |
| Park medi World Ltd. | 139.35 | 26.71% | 15.30% | 17.47% | 0.61 | 6997.27 | 32.82 |
| Apollo Hospitals Enterprise Limited | 21794 | 14% | 6.91% | 16.60% | 0.88 | 103409 | 62 |
| Fortis Healthcare Limited | 7783 | 20% | 10.39% | 12.00% | 0.34 | 67342 | 66.8 |
| Global Health Limited | 3692 | 24% | 13.02% | 19.70% | 0.25 | 31161 | 52.2 |
| Jupiter Lifeline Hospitals Limited | 1262 | 24% | 15.37% | 18.00% | 0.28 | 9393 | 47 |
| Krishna Institute of Medical Sciences Limited | 3035 | 26% | 13.67% | 15.00% | 1.4 | 27966 | 85.1 |
| Max Healthcare Institute Limited | 7028 | 26% | 15.31% | 14.90% | 0.33 | 106032 | 75 |
| Narayana Hrudalaya Limited | 5483 | 24% | 14.24% | 20.80% | 0.56 | 39582 | 46.5 |
| Yatharth Hospital & Trauma Care Services Limited | 860 | 26% | 15.23% | 14% | 0.02 | 6576 | 43.1 |
| Note : Forward P/E 25.15 is According to FY26 PAT | |||||||
Lead Manager of Park Medi World Limited IPO:
Registrar of Park Medi World Limited IPO:
Discussion on Park Medi World Limited IPO:
Leave a Reply
You must be logged in to post a comment.